E62: Elizabeth Holmes verdict, fraud origins & takeaways, navigating "The Great Markdown" & more
Chamath Palihapitiya (host), Jason Calacanis (host), David Friedberg (host), Jason Calacanis (host), Chamath Palihapitiya (host), David Sacks (host), David Sacks (host), David Friedberg (host)
In this episode of All-In Podcast, featuring Chamath Palihapitiya and Jason Calacanis, E62: Elizabeth Holmes verdict, fraud origins & takeaways, navigating "The Great Markdown" & more explores elizabeth Holmes verdict, fraud lessons, and startup survival in downturns The hosts dissect Elizabeth Holmes’ fraud conviction, emphasizing the clear legal line between visionary ambition and lying about a company’s present capabilities, customers, and deals.
Elizabeth Holmes verdict, fraud lessons, and startup survival in downturns
The hosts dissect Elizabeth Holmes’ fraud conviction, emphasizing the clear legal line between visionary ambition and lying about a company’s present capabilities, customers, and deals.
They explore how media hype, social proof, and investor herd behavior helped enable Theranos, while sophisticated Silicon Valley VCs largely stayed away due to obvious red flags.
The conversation shifts to the broader market: a sharp valuation correction in tech and SaaS, Fed policy whiplash, and what this means for the 900+ unicorns and late-stage private companies.
They close with practical advice for founders on capital efficiency, becoming or approaching “default alive,” focusing on real unit economics, and preparing to build through a potentially tougher funding environment.
Key Takeaways
Founders can sell a big vision, but must never misrepresent present reality.
The clear legal line in the Holmes case was lying about existing customers, partnerships, and product capabilities; you can be messianic about the future, but must be precise and honest about what works today.
Get the full analysis with uListen AI
Media hype and social proof can create self-reinforcing fraud cycles.
Holmes amplified her story because each bigger claim led to more glowing coverage, which in turn attracted investors, partners, and talent—until that same narrative gave journalists incentives to tear her down.
Get the full analysis with uListen AI
Do your own diligence; never outsource thinking to reputations or headlines.
Theranos investors often relied on big names (Murdoch, DeVos, ex–secretaries, generals) and flattering press instead of independent checks; sophisticated VCs passed precisely because they pushed for technical and financial transparency.
Get the full analysis with uListen AI
The “one drop of blood for hundreds of tests” claim is still mostly science fiction.
While microfluidics and certain assays (e. ...
Get the full analysis with uListen AI
Tech and SaaS are undergoing a major multiple compression driven by Fed policy.
Loose monetary policy inflated growth-stock and SaaS revenue multiples far above historical norms; with the Fed tightening faster and signaling balance-sheet shrinkage, high-multiple names have corrected sharply, and some further mean reversion is possible.
Get the full analysis with uListen AI
Many unicorns will face flat or down exits, not blockbuster IPOs.
With ~900 unicorns and large acquirers constrained by antitrust, many overvalued private companies will likely sell for around or below their last round (VCs just getting their money back via preferences), or be forced into painful re-ratings before going public.
Get the full analysis with uListen AI
Founders must prioritize capital efficiency: approach default alive and manage burn multiple.
In choppy markets, it’s not enough to chase topline growth—companies need sensible burn relative to ARR added, focus spending on product/marketing/sales, and, where possible, move toward profitability so they’re less dependent on fickle capital markets.
Get the full analysis with uListen AI
Notable Quotes
“As a founder, you can be as messianic as you want to be… but you must be accurate about the current state of your business.”
— David Sacks
“The more she said, the bigger she said it, the more she claimed she could do, the bigger the story got… and the whole thing became this kind of reinforcing cycle.”
— David Friedberg
“When you start working with the media in this way to promote your company, you're playing with fire because the media really has two kinds of stories. They build up and they tear down.”
— David Sacks
“The argument of unprofitable growth is a vestige of fund dynamics and VCs who wanna raise larger and larger funds to line their pockets with fees.”
— Chamath Palihapitiya
“If you can achieve those six things, in that order, every step of the way… you can build the next Google.”
— David Friedberg
Questions Answered in This Episode
Where should regulators and prosecutors draw the line between aggressive startup storytelling and criminal fraud, especially in frontier tech like biotech?
The hosts dissect Elizabeth Holmes’ fraud conviction, emphasizing the clear legal line between visionary ambition and lying about a company’s present capabilities, customers, and deals.
Get the full analysis with uListen AI
How can founders leverage media and brand-building without creating expectations that outpace scientific or product reality?
They explore how media hype, social proof, and investor herd behavior helped enable Theranos, while sophisticated Silicon Valley VCs largely stayed away due to obvious red flags.
Get the full analysis with uListen AI
In a post-Theranos world, what concrete diligence steps should investors and large partners (like Walgreens) take before backing deep-tech or life sciences startups?
The conversation shifts to the broader market: a sharp valuation correction in tech and SaaS, Fed policy whiplash, and what this means for the 900+ unicorns and late-stage private companies.
Get the full analysis with uListen AI
Given the current valuation reset and Fed tightening, how should late-stage unicorns rethink their exit strategies and internal spending plans?
They close with practical advice for founders on capital efficiency, becoming or approaching “default alive,” focusing on real unit economics, and preparing to build through a potentially tougher funding environment.
Get the full analysis with uListen AI
For early-stage founders, what is the right balance between optimizing for a high valuation today versus ensuring long-term funding flexibility and healthy unit economics?
Get the full analysis with uListen AI
Transcript Preview
Happy New Year.
Happy New Year.
Happy New Year. Guys, listen. Look at- look at this.
Happy New Year.
It's now, it's candle season.
Oh, God. Look at the equanimity.
This is-
Look at his equanimity.
This candle costs $24,000. It is an-
(laughs)
... extremely rare Brazilian sandalwood. You literally have to go into the Amazon.
(laughs)
And like, you know, you, you basically have to, like, I mean-
Find distinct trees.
No, bro, you gotta, you gotta tear out, like, two acres of rainforest, and then you find this one tree completely, you know-
Yeah.
... sacred.
Mm-hmm.
Uh, and then you chop it down. You make this delicious, decendente scent.
Then you produce it and, and it lasts for a full 45 minutes.
How do you like that sweater, Karen? Happy New Year.
(laughs) Candle Karens are gonna be calling you.
Candle Karen.
Candle Karens are calling you right now. The DMs are coming.
You guys wanna hear about poker last night?
Oh, did you go?
So I go down, I take my eight-hour drive down south to Chamath's house.
(laughs)
And I pull in and, uh, you know, the security guard greets me nicely as always. I walk in, and I walk towards the poker room, and everyone's in there with the door open like someone just got shot, masks on, freaking out, and Chamath is inside the house and I wave and he's like, "Get in here." And then I go in and he's like-
Who, uh-oh, who was positive?
Max, the dealer, tested positive.
Max, the dealer.
And everyone had been hanging out in the poker room with no masks on.
Uh-oh, uh-oh.
And so-
Another super-spreader.
Wait, wait, but hold on. The only, the only two people that were exposed to Max we sent home.
Yeah, so everyone starts freaking out. He shuts the, the, he shuts the poker game down, Chamath kicks everyone out, sends everyone home. And then he's like, "All right, let's go have dinner inside. You know, we're, we're not, we're gonna... We opened up all the doors, we're gonna kind of Lysol the room tomorrow. We all go in, have dinner." Or, you know, Chamath and I go in and have dinner with Matt and the kids. And then Chamath starts thinking, "You know what? It's okay. Th- they were only exposed for a few seconds. Let's call Phil back. Okay, let's call Shifel back. Let's call Keating back." And then they all come back for dinner, and at this point it's become, like, a dinner party, and then a couple glasses of wine in, and then it's like-
Uh-oh.
... "You know what? The room's probably safe. We should go back and play poker."
(laughs)
(laughs)
Install uListen to search the full transcript and get AI-powered insights
Get Full TranscriptGet more from every podcast
AI summaries, searchable transcripts, and fact-checking. Free forever.
Add to Chrome